End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 48 | 20-03-29 |
Anuj Gaggar
CTO | Chief Tech/Sci/R&D Officer | 46 | 11-07 |
William Delaney
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-05-31 |
John McHutchison
BRD | Director/Board Member | 66 | 19-08-05 |
Shannon Ryan
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | - | 19-07-31 | |
General Counsel | - | 22-08-31 | |
Nicole White
PRN | Corporate Officer/Principal | 44 | 20-11-16 |
Human Resources Officer | - | 17-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Mahony
BRD | Director/Board Member | 59 | 17-12-13 |
Gina Consylman
BRD | Director/Board Member | 52 | 20-10-19 |
William Ringo
CHM | Chairman | 78 | 14-06-30 |
Anthony Altig
BRD | Director/Board Member | 68 | 11-12-31 |
Jason Okazaki
CEO | Chief Executive Officer | 48 | 20-03-29 |
Michael Houghton
BRD | Director/Board Member | 73 | 21-07-18 |
John McHutchison
BRD | Director/Board Member | 66 | 19-08-05 |
Tomas Cihlar
BRD | Director/Board Member | 57 | 12-06 |
Director/Board Member | 60 | 21-05-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,513,308 | 3,690,474 ( 66.94 %) | 0 | 66.94 % |
Company contact information
Assembly Biosciences, Inc.
Two Tower Place 7th floor
94080, South San Francisco
+833 509 4583
http://www.assemblybio.comSector
1st Jan change | Capi. | |
---|---|---|
+8.54% | 72.5B | |
+13.69% | 9.11B | |
-11.75% | 5.07B | |
+59.61% | 5.01B | |
+2.62% | 3.85B | |
-17.54% | 2.46B | |
+21.10% | 2.44B | |
-27.82% | 2.26B | |
+25.13% | 2.27B |
- Stock Market
- Equities
- ASMB Stock
- Stock
- Company Ventrus Biosciences Inc